Search Results for “New LFCA Test Score Report Free PDF | Valid LFCA Test Questions: Linux Foundation Certified IT Associat 🥅 Search on ⏩ www.pdfvce.com ⏪ for ⇛ LFCA ⇚ to obtain exam materials for free download 🌱LFCA Vce Exam” – Page 2

Publications

Publications Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD Use: Start with an overview of all publications. Use tag links to list selected documents or

Personal Background

Personal Background Prof. Dr. med. Marcus Maurer Executive Director of the Institute of Allergology at the Charité – Universitätsmedizin Berlin Co-Director of Immunology and Allergology at the

Comparison of urticaria activity score over 7 days (UAS7) values obtained from once-daily and twice-daily versions: results from the ASSURE-CSU study

303

Hollis, K.+, Proctor, C., McBride, D., Balp, M. M., McLeod, L., Hunter, S., Tian, H., Khalil, S., and Maurer, M.: Comparison of urticaria activity score over 7 days (UAS7) values obtained from once-daily and twice-daily versions: results from the ASSURE-CSU study. Am. J. Clin. Dermatol. 2018: 19; 267-274. IF: 3.84

313	Maurer, M. Mathias, S. D., Crosby, R. D., Rajput, Y.+, and Zazzali, J. L.: Validity and responsiveness of the urticaria activity and impact measure: a new patient-reported tool. Ann. Allergy Asthma Immunol. 2018: 120; 641-647. IF: 3.56

365	Kulthanan, K., Chularojanamontri, L., Rujitharanawong, C., Weerasubpong, P., Weller, K., and Maurer, M.+: Angioedema activity score (AAS): a valid and reliable tool to use in Asian patients. Biomed. Res. Int. 2019: 9157895. IF: 2.28

o.365

296	Ruft, J., Asady, A., Staubach, P., Casale, T., Sussman, G., Zuberbier, T., Maurer, M. Weller, K., and Altrichter, S.+: Development and validation of the cholinergic urticaria quality of life questionnaire: CholU-QoL. Clin. Exp. Allergy 2018: 48; 433-444. IF: 4.74

233	Kulthanan, K., Chularojanamontri, L.+, Tuchinda, P., Rujitharanawong, C., Maurer, M. and Weller, K.: Validity, reliability and interpretability of the Thai version of the urticaria control test (UCT). Health Qual. Life Outcomes 2016: 14; 61-70. IF: 2.14

Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria

125

Mathias, S. D.+, Crosby, R. D., Zazzali, J. L., Maurer, M. and Saini, S. S.: Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria. Ann. Allergy Asthma Immunol. 2012: 108; 20-24. IF: 3.44

398.	Tawil, S.⁺, Irani, C., Kfoury, R., Salameh, P., Baiardini, I., Weller, K., Maurer, M., and Ezzedine, K.: The Arabic urticaria activity score and chronic urticaria quality of life questionnaire: validation and correlations. Int. J. Dermatol. 2020: 59; 893-901. IF: 2.74

o.398

Development and Validation of the Mastocytosis Quality of Life questionnaire: MC-QoL

240

Siebenhaar, F.+, von Tschirnhaus, E., Hartmann, K., Rabenhorst, A., Staubach, P., Peveling-Oberhag, A., Wagner, N., Martus, P., Carter, M. C., Metcalfe, D. D., Church, M. K., Maurer, M. and Weller, K.: Development and Validation of the Mastocytosis Quality of Life questionnaire: MC-QoL. Allergy 2016: 71; 869-877. IF: 7.36

Results